EATSMARTLABS

Health Conditions

Insulin Resistance

A condition in which cells respond less effectively to insulin.

What the research tells us

What the evidence says

Each summary sticks to what the cited source studied and found.

Mediterranean dietary pattern

How strong the evidence is
Moderate
What kind of study it is
Systematic review/meta-analysis of controlled trials

What the study found

A systematic review and meta-analysis of controlled trials found Mediterranean dietary interventions produced beneficial changes in several metabolic outcomes, including fasting insulin and HOMA-IR, a commonly used surrogate measure of insulin resistance.

Limitations

  • HOMA-IR and fasting insulin are surrogate metabolic outcomes.
  • Study populations, intervention designs, and comparator diets varied.
  • Do not equate improvement in insulin-resistance markers with cure or permanent reversal.
  • Effects cannot be attributed to one individual Mediterranean-diet food.
  • Do not infer prevention of Type 2 Diabetes from these markers alone.

What this says about long-term health

Not established by the insulin-resistance outcomes alone.

Sources

Dietary fiber and insulin sensitivity

How strong the evidence is
Moderate
What kind of study it is
Systematic review/meta-analysis and umbrella review of randomized-trial meta-analyses

What the study found

Systematic-review and meta-analytic evidence indicates that dietary fiber interventions can modestly improve fasting insulin and HOMA-IR. A recent meta-analysis in adults with overweight or obesity without Type 2 Diabetes reported reductions in fasting insulin and HOMA-IR following fiber supplementation.

Limitations

  • Fiber sources, types, doses, and intervention durations vary substantially.
  • Statistical heterogeneity is high for several metabolic outcomes.
  • Do not assume all fibers or fiber-containing foods produce identical effects.
  • Do not claim fiber cures or permanently reverses insulin resistance.
  • Study populations should not automatically be generalized to everyone with insulin resistance.
  • Do not infer long-term diabetes prevention from surrogate-marker changes alone.

What this says about long-term health

Not established by these surrogate outcomes alone.

Sources